185 related articles for article (PubMed ID: 38124049)
1. Notch3 restricts metastasis of breast cancers through regulation of the JAK/STAT5A signaling pathway.
Chen MN; Fang ZX; Wu Z; Bai JW; Li RH; Wen XF; Zhang GJ; Liu J
BMC Cancer; 2023 Dec; 23(1):1257. PubMed ID: 38124049
[TBL] [Abstract][Full Text] [Related]
2. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.
Fang F; Rycyzyn MA; Clevenger CV
Endocrinology; 2009 Apr; 150(4):1597-606. PubMed ID: 19036881
[TBL] [Abstract][Full Text] [Related]
3. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
[TBL] [Abstract][Full Text] [Related]
4. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
Sultan AS; Brim H; Sherif ZA
Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
[TBL] [Abstract][Full Text] [Related]
5. Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α.
Dou XW; Liang YK; Lin HY; Wei XL; Zhang YQ; Bai JW; Chen CF; Chen M; Du CW; Li YC; Tian J; Man K; Zhang GJ
Theranostics; 2017; 7(16):4041-4056. PubMed ID: 29109797
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
Linher-Melville K; Singh G
BMC Cancer; 2014 Jun; 14():415. PubMed ID: 24913037
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.
Zeng Y; Min L; Han Y; Meng L; Liu C; Xie Y; Dong B; Wang L; Jiang B; Xu H; Zhuang Q; Zhao C; Qu L; Shou C
Carcinogenesis; 2014 Oct; 35(10):2244-53. PubMed ID: 24925029
[TBL] [Abstract][Full Text] [Related]
8. Notch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cells.
Chen CF; Dou XW; Liang YK; Lin HY; Bai JW; Zhang XX; Wei XL; Li YC; Zhang GJ
Cell Cycle; 2016; 15(3):432-40. PubMed ID: 26694515
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer.
Koptyra M; Gupta S; Talati P; Nevalainen MT
Int J Biochem Cell Biol; 2011 Oct; 43(10):1417-21. PubMed ID: 21704724
[TBL] [Abstract][Full Text] [Related]
10. Notch3 Transactivates Glycogen Synthase Kinase-3-Beta and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer Cells.
Chen W; Zhang Y; Li R; Huang W; Wei X; Zeng D; Liang Y; Zeng Y; Chen M; Zhang L; Gao W; Zhu Y; Li Y; Zhang G
Cells; 2022 Sep; 11(18):. PubMed ID: 36139447
[TBL] [Abstract][Full Text] [Related]
11. Signal transducer and activator of transcription 5A/B in prostate and breast cancers.
Tan SH; Nevalainen MT
Endocr Relat Cancer; 2008 Jun; 15(2):367-90. PubMed ID: 18508994
[TBL] [Abstract][Full Text] [Related]
12. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.
Craig JM; Turner TH; Harrell JC; Clevenger CV
Endocrinology; 2021 May; 162(5):. PubMed ID: 33589921
[TBL] [Abstract][Full Text] [Related]
13. HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.
Medler TR; Craig JM; Fiorillo AA; Feeney YB; Harrell JC; Clevenger CV
Mol Cancer Res; 2016 Oct; 14(10):994-1008. PubMed ID: 27358110
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA T cell leukemia homeobox 1 neighbor enhances signal transducer and activator of transcription 5A phosphorylation to promote colon cancer cell invasion, migration, and metastasis.
Chen G; Lian D; Zhao L; Wang Z; Wuyun Q; Zhang N
Bioengineered; 2022 Apr; 13(4):11083-11095. PubMed ID: 35502613
[TBL] [Abstract][Full Text] [Related]
15. STAT5A is regulated by DNA damage via the tumor suppressor p53.
Mukhopadhyay UK; Cass J; Raptis L; Craig AW; Bourdeau V; Varma S; SenGupta S; Elliott BE; Ferbeyre G
Cytokine; 2016 Jun; 82():70-9. PubMed ID: 26876578
[TBL] [Abstract][Full Text] [Related]
16. Progesterone induction of the 11beta-hydroxysteroid dehydrogenase type 2 promoter in breast cancer cells involves coordinated recruitment of STAT5A and progesterone receptor to a distal enhancer and polymerase tracking.
Subtil-Rodríguez A; Millán-Ariño L; Quiles I; Ballaré C; Beato M; Jordan A
Mol Cell Biol; 2008 Jun; 28(11):3830-49. PubMed ID: 18378698
[TBL] [Abstract][Full Text] [Related]
17. An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma.
Tan D; Chen KE; Deng C; Tang P; Huang J; Mansour T; Luben RA; Walker AM
Cancer Lett; 2014 Apr; 346(1):148-57. PubMed ID: 24384092
[TBL] [Abstract][Full Text] [Related]
18. Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.
Tang JZ; Zuo ZH; Kong XJ; Steiner M; Yin Z; Perry JK; Zhu T; Liu DX; Lobie PE
Endocrinology; 2010 Jan; 151(1):43-55. PubMed ID: 19966185
[TBL] [Abstract][Full Text] [Related]
19. Involvement of STAT5a signaling in morphine-induced up-regulation of the cyclin D1.
Guo L; Li H; Liu H; Li C; Li M; Jiang W; He P; Wang S; McNutt MA; Li G
Biochem Pharmacol; 2009 May; 77(9):1553-60. PubMed ID: 19426693
[TBL] [Abstract][Full Text] [Related]
20. Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer.
Woock AE; Grible JM; Olex AL; Harrell JC; Zot P; Idowu M; Clevenger CV
Sci Rep; 2021 Jun; 11(1):13506. PubMed ID: 34188118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
